Literature DB >> 3092850

Extracorporeal circuit sequestration of fentanyl and alfentanil.

M Skacel, C Knott, F Reynolds, C Aps.   

Abstract

Fentanyl or alfentanil, in doses approximating to those used in clinical practice, was added to the priming fluid of an extracorporeal circuit before the institution of cardiopulmonary bypass (CPB). The concentrations of both drugs in the priming fluid were measured over a 20-min period. The concentration of fentanyl decreased at neutral or high pH values, suggesting drug adsorption to the circuit. The concentration of alfentanil was unaffected. The administration of fentanyl to the priming fluid may produce lower anaesthetic concentrations than anticipated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3092850     DOI: 10.1093/bja/58.9.947

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  11 in total

Review 1.  Optimising drug dosing in patients receiving extracorporeal membrane oxygenation.

Authors:  Vesa Cheng; Mohd-Hafiz Abdul-Aziz; Jason A Roberts; Kiran Shekar
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 2.  The pharmacokinetic behaviour of opioids administered during cardiac surgery.

Authors:  R Hall
Journal:  Can J Anaesth       Date:  1991-09       Impact factor: 5.063

Review 3.  Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients.

Authors:  Federico Pea; Federica Pavan; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.

Authors:  J Scholz; M Steinfath; M Schulz
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

5.  Medication adsorption into contemporary extracorporeal membrane oxygenator circuits.

Authors:  Aaron A Harthan; Klayton W Buckley; Margaret L Heger; Randall S Fortuna; Kyle Mays
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

6.  Determinants of drug absorption in different ECMO circuits.

Authors:  E D Wildschut; M J Ahsman; K Allegaert; R A A Mathot; D Tibboel
Journal:  Intensive Care Med       Date:  2010-09-23       Impact factor: 17.440

7.  Recall of intraoperative events after general anaesthesia and cardiopulmonary bypass.

Authors:  A A Phillips; R F McLean; J H Devitt; E M Harrington
Journal:  Can J Anaesth       Date:  1993-10       Impact factor: 5.063

Review 8.  Neurological and psychiatric adverse effects of anaesthetics: epidemiology and treatment.

Authors:  J M Klafta; J P Zacny; C J Young
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

9.  The effect of cardiopulmonary bypass on plasma protein binding of alfentanil.

Authors:  K Kumar; D P Crankshaw; D J Morgan; G H Beemer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 10.  Cardiopulmonary bypass and the pharmacokinetics of drugs. An update.

Authors:  W A Buylaert; L L Herregods; E P Mortier; M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1989-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.